Avalign Technologies’ Acquisition of the Assets of Thortex
| Client | Avalign Technologies is a Bannockburn, Illinois-based medtech contract manufacturer selling instruments, cutting tools and cases and trays to mid-range orthopedic OEM customers | 
|---|---|
| Ownership | Avalign is a portfolio company of Washington D.C.-based Arlington Capital Partners | 
| Seller | Thortex is a Portland, Oregon-based manufacturer of metal machined orthopedic implants, a proprietary coating process for implants and patented titanium metal injection molding (Ti MIM) manufacturing technology | 
| Transaction | Avalign acquired 100% of the assets of Thortex | 
| Consideration | Cash plus earn-out | 
| Valuation | Undisclosed | 
- 
  
Situation Review
- KGI was engaged by Avalign to execute an acquisition search assignment focused on orthopedic implants and later expanded to include instrument manufacturers in the U.S. and Europe
 - KGI understood and appreciated the value of the proprietary Ti MIM and coating technologies at Thortex
 
 - 
  
Transaction Process
- KGI had long established first-hand knowledge of Thortex and its operations developed over a period of six years, having visited the facility numerous times, and a well-established personal relationship with ownership
 - Thortex was introduced to Avalign by KGI well before the Owners’ decision to sell; this allowed for quick response by Avalign when the Owners reached decision to sell based on owner’s health
 
 - 
  
Outcomes
- The transaction broadened the size and scope of Avalign’s product offerings to its OEM customers
 - New manufacturing technology is very hard to acquire and this puts Avalign as one of three industry leaders with Ti MIM at the point of commercialization
 - The addition of surface coatings makes Avalign the second major contract manufacturer with such in-house capability
 
 
